Ubs Group Ag Xortx Therapeutics Inc. Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.73 - $10.71 $48 - $706	66 New	66 $0
Q2 2022 Aug 10, 2022	BUY	$1.16 - $1.97 $2,316 - $3,934	1,997 Added 53.91%	5,701 $8,000
Q1 2022 May 16, 2022	BUY	$1.16 - $2.15 $3,006 - $5,572	2,592 Added 233.09%	3,704 $7,000
Q4 2021 Feb 14, 2022	BUY	$1.8 - $5.84 $2,001 - $6,494	1,112 New	1,112 $2,000

Ticker XRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,389,700
Market Cap $25.2M
Description
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic ki...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.